Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Dressler

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Supplements to Clinical Neurophysiology|August 19, 2005
Botulinum toxin mechanisms of actionDirk Dressler
Journal of Neurology|March 12, 2004
New formulation of BOTOX. Complete antibody-induced therapy failure in hemifacial spasmDirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|February 10, 2010
Comparing Botox and Xeomin for axillar hyperhidrosisDirk Dressler
European Neurology|October 10, 2002
Medicine and the pharmaceutical industryDirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|October 31, 2013
Tardive dystonic syndrome induced by the calcium-channel blocker amlodipineDirk Dressler
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Clinical presentation and management of antibody-induced failure of botulinum toxin therapyDirk Dressler
Brain : a Journal of Neurology|November 30, 2019
OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineDirk Dressler
European Neurology|July 26, 2002
Clinical features of antibody-induced complete secondary failure of botulinum toxin therapyDirk Dressler
Toxicon : Official Journal of the International Society on Toxinology|February 15, 2020
Therapeutically relevant features of botulinum toxin drugsDirk Dressler
Current Opinion in Microbiology|July 10, 2012
Clinical applications of botulinum toxinDirk Dressler
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Supplements to Clinical Neurophysiology|August 19, 2005
Botulinum toxin mechanisms of actionDirk Dressler
Journal of Neurology|March 12, 2004
New formulation of BOTOX. Complete antibody-induced therapy failure in hemifacial spasmDirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|February 10, 2010
Comparing Botox and Xeomin for axillar hyperhidrosisDirk Dressler
European Neurology|October 10, 2002
Medicine and the pharmaceutical industryDirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|October 31, 2013
Tardive dystonic syndrome induced by the calcium-channel blocker amlodipineDirk Dressler
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Clinical presentation and management of antibody-induced failure of botulinum toxin therapyDirk Dressler
Brain : a Journal of Neurology|November 30, 2019
OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineDirk Dressler
European Neurology|July 26, 2002
Clinical features of antibody-induced complete secondary failure of botulinum toxin therapyDirk Dressler
Toxicon : Official Journal of the International Society on Toxinology|February 15, 2020
Therapeutically relevant features of botulinum toxin drugsDirk Dressler
Current Opinion in Microbiology|July 10, 2012
Clinical applications of botulinum toxinDirk Dressler
Pageof 16